Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors (Q36651667)

15 August 2017

Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors (English)

1 reference

15 August 2017

1 reference

3

Peter L Choyke

1 reference

15 August 2017

Kohei Sano

1

1 reference

15 August 2017

Takahito Nakajima

series ordinal

2

1 reference

15 August 2017

Hisataka Kobayashi

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

18 December 2012

1 reference

15 August 2017

1 reference

15 August 2017

7

1 reference

15 August 2017

1

1 reference

15 August 2017

717-724

1 reference

Guided Delivery of Polymer Therapeutics Using Plasmonic Photothermal Therapy

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Macromolecular therapeutics in cancer treatment: the EPR effect and beyond

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Nanocarriers as an emerging platform for cancer therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Drug penetration in solid tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Polymer conjugates: nanosized medicines for treating cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Nano-sized MRI contrast agents with dendrimer cores

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Immunotherapy: past, present and future

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

The pharmacology of monoclonal antibodies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier"

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Tumor measurement in the nude mouse

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

The next frontier of molecular medicine: delivery of therapeutics.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Superparamagnetic iron oxide: pharmacokinetics and toxicity

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Is anticancer drug development heading in the right direction?

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3586604

Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes

20 September 2018

1 reference

12 December 2020

A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II

1 reference

12 December 2020

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma

1 reference

12 December 2020

Monoclonal antibody successes in the clinic

1 reference

12 December 2020

EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy

1 reference

12 December 2020

Nitroglycerin enhances vascular blood flow and drug delivery in hypoxic tumor tissues: analogy between angina pectoris and solid tumors and enhancement of the EPR effect

1 reference

12 December 2020

Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits

1 reference

12 December 2020

Identifiers

DOI

10.1021/NN305011P

1 reference

15 August 2017

1 reference

15 August 2017

1 reference